MedTrace Logo

Revaccination With Pollinex® Quattro

NCT02579720 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 108

Last updated 2023-12-20

No results posted yet for this study

Summary

The purpose of this non interventional study (NIS) was to observe the efficacy of Pollinex® Quattro as a short-term revaccination in patients who have already been successfully desensitized at least five years ago against grass-pollen but developed a recurrent allergy.

Conditions

  • Allergic Rhinitis

Sponsors & Collaborators

  • University Hospital of Cologne

    collaborator OTHER

  • Prof. Dr. Ralph Mösges

    lead OTHER

Principal Investigators

  • Matthias Kramer, Prof. Dr. · Bencard Allergie GmbH

Eligibility

Min Age
12 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2015-10-31
Completion
2015-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02579720 on ClinicalTrials.gov